Abstract
The Prolong study shows that continuing vitamin K antagonists (VKA) in patients with abnormal d-dimer (evaluated by a qualitative assay, Clearview Simplify d-dimer) results in a significant reduction of venous thromboembolism (VTE) recurrence. The present study retrospectively analyzes a subgroup of patients enrolled in the Prolong study with a view to calculate cut-off values for six quantitative d-dimer methods to predict the risk of VTE recurrence. We measured d-dimer levels by VIDAS d-dimer Exclusion (bioMerieux), STA Liatest d-dimer (DiagnosticaStago), HemosIL d-dimer and HemosIL d-dimer HS (Instrumentation Laboratory), Innovance d-dimer (Siemens) and AutoDimer (Trinity Biotech) in frozen plasma aliquots sampled 30 ± 10 days after VKA cessation in 390 patients enrolled in the Prolong study. During follow-up (562.7 years), 28 patients had recurrent VTE (7.2%, 5.0% person-years). Since d-dimer levels are positively correlated with age and significantly lower in men, we calculated method-specific cut-off values according to age and gender. The HRs for VTE recurrence calculated using method-specific cut-off values based on age and gender are higher than those using cut-off values indicated by the manufacturers for VTE exclusion in symptomatic outpatients. These data suggest that method-specific cut-off values calculated according to patient age and gender can be more accurate in identifying patients at a higher risk for VTE recurrence. These method-specific cut-off values are being evaluated in the ongoing prospective management multicenter DULCIS study.
Similar content being viewed by others
References
Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ (2008) Antithrombotic therapy for venous thromboembolic disease. Chest 133:454S–545S
Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S (2002) Risk of venous thromboembolism recurrence: high negative predictive value of d-dimer performed after oral anticoagulation is stopped. Thromb Haemost 87:7–12
Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenbergen P, Schneider B, Weltermann A, Wagner O, Kyrle PA (2003) d-dimer levels and risk of recurrent venous thromboembolism. JAMA 290:1071–1074
Palareti G, Legnani C, Cosmi B, Valdre L, Lunghi B, Bernardi F, Coccheri S (2003) Predictive value of d-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 108:313–318
Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M (2006) d-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost 4:1208–1214
Baglin T, Palmer CR, Luddington R, Baglin C (2008) Unprovoked recurrent venous thrombosis: prediction by d-dimer and clinical risk factors. J Thromb Haemost 6:577–582
Poli D, Antonucci E, Ciuti G, Abbate R, Prisco D (2008) Combination of d-dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal. J Thromb Haemost 6:708–710
Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Lensing AWA, Tripodi A (2006) d-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 355:1780–1789
Verhovsek M, Douketis JD, Yi Q, Shrivastava S, Tait RC, Baglin T, Poli D, Lim W (2008) Systematic review: d-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med 149:481–490
Bruinstroop E, Klok FA, Van De Ree MA, Oosterwijk FL, Huisman MV (2009) Elevated d-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis. J Thromb Haemost 7:611–618
Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Iorio A (2010) Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of d-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann Intern Med 153:523–531
Hager K, Platt D (1995) Fibrin degeneration product concentrations (d-dimers) in the course of ageing. Gerontology 41:159–165
Pieper CF, Rao KMK, Currie MS, Harris TB, Cohen HJ (2000) Age, functional status, and racial differences in plasma d-dimer levels in community-dwelling elderly persons. J Gerontol A Biol Sci Med Sci 55:M649–M657
Harper PL, Theakston E, Ahmed J, Ockelford P (2007) d-dimer concentration increases with age reducing the clinical value of the d-dimer assay in the elderly. Intern Med J 37:607–613
Rudnicka AR, Rumley A, Lowe GDO, Strachan DP (2007) Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin d-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 115:996–1003
Douma RA, le Gal G, Sohne M, Righini M, Kamphuisen PW, Perrier A, Kruip MJ, Bounameaux H, Buller HR, Roy PM (2010) Potential of an age adjusted d-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts. BMJ 340:c1475. doi:10.1136/bmj.c1475
Acknowledgments
We would like to thank bioMerieux (Lyon, France), Instrumentation Laboratory (Milan, Italy), Roche Diagnostics (Monza, Italy) and Siemens (Milan, Italy) for providing all d-dimer reagents, and Stephen Jewkes for editing the English text. This study was supported by the Italian Federation of Thrombosis Centers (FCSA).
Conflict of interest
Drs. Legnani, Palareti, Cosmi, Tripodi report having received lecture fees from Instrumentation Laboratory. Drs. Legnani and Palareti report having received lecture fees also from Roche Diagnostics.
Author information
Authors and Affiliations
Corresponding author
Additional information
On behalf of the Prolong Investigators.
Appendix
Appendix
Study sites and principal investigator (all the participating centers are affiliated in the Italian Federation of Thrombosis Centers—FCSA; number in parentheses are the number of enrolled patients):
U.O. Angiologia e Malattie della Coagulazione “Marino Golinelli”, Policlinico S.Orsola-Malpighi, Bologna—G. Palareti (143, Coordinating Center); A.O. Istituti Ospitalieri, Cremona—S. Testa (60); I° Div. di Medicina Interna—Centro Emostasi e Trombosi, Arcispedale Santa Maria Nuova, Reggio-Emilia—A. Ghirarduzzi (54); Centro Regionale Malattie Emorragiche e Trombotiche—Div. Ematologia, Ospedale S. Bortolo, Vicenza—A. Tosetto (28); Servizio di Prevenzione e Terapia della Trombosi, Ospedale “Ex Busonera”, Padova—V. Pengo (20); Sezione Trasfusionale, Ospedale San Leopoldo Mandic, Merate—N. Erba (17); Centro Sorveglianza Anticoagulati—Malattie della Coagulazione e Angiologia Medica—Div. di Med. Interna, Ospedale “S. Cuore di Gesu’“, Gallipoli—L. Ria (13); Centro Emostasi, Ospedale Regionale, Parma—C. Pattacini (13); Laboratorio Analisi—Divisione di Cardiologia, Ospedale di Bentivoglio—E. Cerè (11); Laboratorio Analisi—Ambulatorio per il Controllo della Terapia Anticoagulante Orale, Presidio Ospedaliero di Faenza—E. Bucherini (11); Laboratorio di Patologia Clinica, Presidio Ospedaliero S.Maria Incoronata dell’Olmo, Cava dei Tirreni—C. Villani (8); Centro Trombosi, A.O. di Careggi Universita’ di Firenze—D. Prisco (5); U.O. Medicina Interna, Policlinico Universitario Messina—A. Trifiletti (5); Centro per lo Studio delle Coagulopatie a Rischio Trombotico, Osp. Galliera, Genova—A. Schenone (2).
Rights and permissions
About this article
Cite this article
Legnani, C., Cini, M., Cosmi, B. et al. Age and gender specific cut-off values to improve the performance of d-dimer assays to predict the risk of venous thromboembolism recurrence. Intern Emerg Med 8, 229–236 (2013). https://doi.org/10.1007/s11739-011-0608-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-011-0608-5